首页> 外文OA文献 >Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk
【2h】

Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk

机译:为考虑遗传性非息肉病结直肠癌风险的基因检测的个人提供决策帮助的随机试验

摘要

BACKGROUND. Despite the potential benefits of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) risk, individuals can find the genetic testing decision-making process complicated and challenging. The goal of the current study was to measure the effectiveness of a tailored decision aid designed specifically to assist individuals to make informed decisions regarding genetic testing for HNPCC risk. METHODS. In all, 153 individuals were randomized to receive the decision aid or a control pamphlet at the end of their first genetic counseling consultation. Of these, 109 (71.2%) completed the first questionnaire 1 week after consultation, whereas 95 (62.1%) completed the 6-month follow-up questionnaire. RESULTS. Although the decision aid had no significant effect on postdecisional regret or actual genetic testing decision, the trial results demonstrated that participants who received the decision aid had significantly lower levels of decisional conflict (ie, uncertainty) regarding genetic testing (chi-square(1) = 8.97; P = .003) and were more likely to be classified as having made an informed choice concerning genetic testing (chi-square(1) = 4.37; P = .037) than participants who received a control pamphlet. Also, men who received the decision aid had significantly higher knowledge levels regarding genetic testing compared with men who received the control pamphlet, whereas no such differences were found for women (chi-square(2) = 6.76; P = .034). CONCLUSIONS. A decision aid for individuals considering genetic testing for HNPCC is an effective intervention to reduce uncertainty and assist individuals to make an informed choice regarding genetic testing for HNPCC after genetic counseling.
机译:背景。尽管基因测试对于遗传性非息肉性结直肠癌(HNPCC)风险具有潜在的好处,但个人仍会发现基因测试的决策过程复杂而富有挑战性。本研究的目的是衡量专门为帮助个人就HNPCC风险的基因检测做出知情决定的量身定制的决策辅助工具的有效性。方法。共有153名患者在第一次遗传咨询结束时被随机分配接受决策帮助或对照手册。其中,有109名(71.2%)完成了咨询后1周的第一份问卷,而有95名(62.1%)完成了为期6个月的随访问卷。结果。尽管决策辅助对决策后悔或实际基因测试决策没有显着影响,但试验结果表明,接受决策辅助的参与者在基因测试方面的决策冲突(即不确定性)水平明显较低(卡方[1] = 8.97; P = 0.003),与接受对照手册的参与者相比,更有可能被归类为在基因检测方面做出了明智的选择(卡方(1)= 4.37; P = .037)。此外,接受决策辅助的男性与接受对照小册子的男性相比,具有更高的基因检测知识水平,而女性则没有这种差异(卡方(2)= 6.76; P = .034)。结论。对于考虑对HNPCC进行基因检测的个人而言,其决策辅助是一种有效的干预措施,可减少不确定性并帮助个人在遗传咨询后就HNPCC的基因检测做出明智的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号